Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06168604 · ClinicalTrials.gov registry record · NA

Evaluating the Efficacy of the Pain Identification and Communication Toolkit

A NA study of Alzheimer Disease and Dementia, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
440
Enrollment target
1
Study location

NCT06168604 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 440 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06168604, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techniques. It will recruit participants from programs of all-inclusive care for the elderly (PACE) and partnering health care clinics. The investigators hypothesize that PICT will help caregivers to recognize and communicate about pain in their care recipients.

Interventions

  • BEHAVIORAL Pain Identification and Communication Toolkit
  • BEHAVIORAL Health Promotion Program

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2023-12-14
Est. Completion 2027-10-30
Phase NA

What the Registry Record Tells You About NCT06168604

The ClinicalTrials.gov registry entry for NCT06168604 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Pain Identification and Communication Toolkit is the first listed.

NCT06168604 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06168604 about?

NCT06168604 is a clinical study titled "Evaluating the Efficacy of the Pain Identification and Communication Toolkit". This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techni...

What is the current status of trial NCT06168604?

This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2023-12-14. Estimated completion is 2027-10-30.

What conditions does trial NCT06168604 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Cognitive Impairment, Pain, Chronic, Caregiver Burden.

What interventions are being tested in trial NCT06168604?

The interventions under investigation include: Pain Identification and Communication Toolkit (BEHAVIORAL), Health Promotion Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06168604?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06168604 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.